Feasibility of HIV Pre-Exposure Prophylaxis as Part of Routine Care in Toronto, Canada

J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):e80-1. doi: 10.1097/QAI.0000000000001004.

Authors

Jason Rajchgot¹, Reed A C Siemieniuk, Nirojini Sivachandran, Pauline Murphy, Andrea Sharp, Angela Cicci, Isaac I Bogoch

Affiliation

¹ *Department of Medicine, University of Toronto, Toronto, ON, Canada †Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada ‡Immunodeficiency Clinic, Toronto General Hospital, Toronto, ON, Canada §Divisions of Internal Medicine and Infectious Diseases, University Health Network, Toronto, ON, Canada.

PMID: 27035886
DOI: 10.1097/QAI.0000000000001004

No abstract available

MeSH terms

Administration, Oral
Adult
Anti-HIV Agents / administration & dosage*
Canada
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination / administration & dosage*
Feasibility Studies
Female
Follow-Up Studies
HIV Infections / prevention & control*
HIV Infections / transmission
Humans
Male
Middle Aged
Pre-Exposure Prophylaxis*
Retrospective Studies
Young Adult

Substances

Anti-HIV Agents
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination